AXSM | Axsome TherapeuticsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$139.61
+$3.60 (+2.65%)

Axsome Therapeutics (AXSM) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2017.

The 50 SMA has sat below the 200 on the daily since Oct 2026, with no cross projected inside the 30 bars Cruxta tracks. On both the daily and the 4-hour, price sits below the 50 and the 200; on the weekly it is between the two.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
below both $139.61 vs 50 $182.01 / 200 $198.95
Projection
No cross projected
Test
No active test
Last cross
Death cross 14 Oct 2026 ยท projected 26 bars out

Weekly as of 30 Oct 16:00 ET

Price
between the two $144.43 vs 50 $191.79 / 200 $114.15
Projection
No cross projected
Test
No active test
Last cross
Golden cross week of 24 Apr 2023 ยท projected 17 bars out

4-hour as of 3 Nov 13:30 ET

Price
below both $142.17 vs 50 $160.23 / 200 $207.40
Projection
No cross projected
Test
No active test
Last cross
Death cross 25 Aug 2026 ยท projected 30 bars out

Cross history

35
crosses on record since 2017
17 golden18 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
14 Oct 2026Death steepdaily26 bars outNot tested
25 Aug 2026Death4-hour30 bars outNot tested
17 Apr 2026Golden4-hour21 bars outNot tested
27 Mar 2026Death4-hour24 bars out2 bar cross test
25 Aug 2025Golden4-hour18 bars outโ€”

About AXSM

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$132M
4-hour coverageYes, since Oct 2025
History on recordSince 2017
SectorHealthcare
Cap bandlarge

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.